Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.

American journal of Alzheimer's disease and other dementias - 1 Feb 2016

Foley Jessica M, Salat David H, Stricker Nikki H, McGlinchey Regina E, Milberg William P, Grande Laura J, Leritz Elizabeth C

Abstract excerpt

We examined the interactive effects of apolipoprotein ∊4 (APOE-∊4), a risk factor for Alzheimer's disease (AD), and diabetes risk on cortical thickness among 107 healthy elderly participants; in particular, participants included 27 APOE-∊4+ and 80 APOE-∊4- controls using T1-weighted structural magnetic resonance imaging. Regions of interests included select frontal, temporal, and parietal cortical regions. Among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cerebral Cortex

Share to Cerebrovascular Disorders

Share to Diabetes Mellitus

Share to Healthy Volunteers

Share to Image Processing, Computer-Assisted

Share to Parietal Lobe

Source

Open in PubMed Open full text

Identifiers

PMID: 26006791
DOI: 10.1177/1533317515587084
PMCID: PMC4913470

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.PMID 26006791Read ↗

Impaired fasting glucose is associated with increased regional cerebral amyloid.Semantic proximity Read ↗

Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.Semantic proximity Read ↗

Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease.Semantic proximity Read ↗

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.Semantic proximity Read ↗

Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.Semantic proximity Read ↗

Differences in Alzheimer's Disease-Related Pathology Profiles Across Apolipoprotein Groups.Semantic proximity Read ↗

Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer’s Disease and Related DementiasSemantic proximity Read ↗

Tau-related reduction of glucose metabolism in mild cognitive impairment occurs independently of APOE ε4 genotype and is gradually modulated by β-amyloidSemantic proximity Read ↗

APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuumSemantic proximity Read ↗

Cortical thinning in temporal pole, a core region in Alzheimer’s disease, in non-demented, middle-aged <i>APOE</i> -ε4 and <i>PICALM</i> -AA/AG carriersSemantic proximity Read ↗

Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76.Semantic proximity Read ↗

Genetic influences on brain and cognitive health and their interactions with cardiovascular conditions and depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.